Pfizer secures up to $1.5B to test a monthly GLP-1 shot
commentaryThe Rundown AINov 16, 2026
Blackstone will fund up to $1.5B for Pfizer’s experimental monthly GLP-1 drug as larger trials test whether fewer injections can sustain weight loss.
Impact: LowConfidence: MediumNovelty: Incremental
commentarythe-rundown-ai